Live Breaking News & Updates on Holding Ag Key

Stay updated with breaking news from Holding ag key. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-Adhoc: Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Conference Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences 27-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer. ....

United States , University Of Washington , University Of Wisconsin , Phenylbutyrate Acer , Jim Denike , Michael Miller , Hans Vitzthum , Las Vegas , Robert Steiner , Chris Schelling , Robertd Steiner , Raghuram Ram Selvaraju , Jack Weinstein , Advita Lifescience Gmb , Stephen Cederbaum , University Of California , Genetic Metabolic Dieticians International , Stock Exchange , Rx Communications Group , Holding Ag Key , News Service , Acer Therapeutics Inc , Society For Inherited Metabolic Disorders , Drug Administration , Pharma Research , Swiss Exchange ,

Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patien

RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update27-Jan-2022 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient. ....

Michael Miller , Jack Weinstein , Jonathan Javitt , Advita Lifescience Gmb , Pharma Research , Swiss Exchange , Nrx Pharmaceuticals Inc , Rx Communications Group , Holding Ag Key , Neurorx Inc , Announced Receipt , Initial Report , Patient Safety , Try Use , Aviptadil During Omicron , Federal Right , Try Law , Vasoactive Intestinal Peptide , License Agreement , Acer Therapeutics , Urea Cycle Disorders , Maple Syrup Urine , Advita Lifescience Gmbh , Financial Officer ,

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from ....

Michael Miller , Jack Weinstein , Jonathan Javitt , Advita Lifescience Gmb , Pharma Research , Swiss Exchange , Nrx Pharmaceuticals Inc , Rx Communications Group , Holding Ag Key , News Service , Neurorx Inc , Announced Receipt , Initial Report , Patient Safety , Try Use , Aviptadil During Omicron Surge , Aviptadil During Omicron , Federal Right , Try Law , Vasoactive Intestinal Peptide , License Agreement , Acer Therapeutics , Urea Cycle Disorders , Maple Syrup Urine , Advita Lifescience Gmbh , Financial Officer ,

Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upco

RELIEF THERAPEUTICS Holding AG / Key word(s): Conference27-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SI. ....

United States , University Of Washington , University Of Wisconsin , Phenylbutyrate Acer , Jim Denike , Michael Miller , Hans Vitzthum , Las Vegas , Robert Steiner , Chris Schelling , Robertd Steiner , Raghuram Ram Selvaraju , Jack Weinstein , Advita Lifescience Gmb , Stephen Cederbaum , University Of California , Genetic Metabolic Dieticians International , Stock Exchange , Rx Communications Group , Holding Ag Key , Acer Therapeutics Inc , Society For Inherited Metabolic Disorders , Drug Administration , Pharma Research , Swiss Exchange , Wisconsin Newborn Screening Program Medical Consultant ,

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application ....

Paolo Galfetti , Michael Miller , Jack Weinstein , Advita Lifescience Gmb , Nuvo Pharmaceuticals Inc , Pharma Research , Drug Administration , Assertio Therapeutics Inc , Swiss Exchange , Rx Communications Group , Holding Ag Key , Trademark Office , News Service , Neurorx Inc , Therapeutic Wholly Owned Subsidiary , Receives Notice , Application Covering Ready , Use Diclofenac Stick Packs , Use Diclofenac Stick , Patent Application , Non Steroidal Anti Inflammatory , Diclofenac Potassium , Strengthens Proprietary Position , Use Diclofenac Packs , Assertio Therapeutics , Miravo Healthcare ,